mGluR3 NAMs (Domain Therapeutics)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NamemGluR3 NAMs (Domain Therapeutics)
Drug Alias NameDT-010991
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMetabotropic glutamate receptor 3 modulators
TargetsMetabotropic glutamate receptor 3
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesDomain Therapeutics SA
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDomain Therapeutics SA
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A